KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Moderna (MRNA) Receivables - Other (2017 - 2026)

Moderna (MRNA) has disclosed Receivables - Other for 10 consecutive years, with $39.0 million as the latest value for Q1 2026.

  • For Q1 2026, Receivables - Other fell 26.42% year-over-year to $39.0 million; the TTM value through Mar 2026 reached $39.0 million, down 26.42%, while the annual FY2025 figure was $42.0 million, 28.81% down from the prior year.
  • Receivables - Other hit $39.0 million in Q1 2026 for Moderna, down from $42.0 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $62.0 million in Q1 2024 and bottomed at $3.0 million in Q1 2022.
  • Average Receivables - Other over 5 years is $46.6 million, with a median of $52.5 million recorded in 2023.
  • Year-over-year, Receivables - Other tumbled 66.67% in 2022 and then soared 1300.0% in 2023.
  • Moderna's Receivables - Other stood at $61.0 million in 2022, then decreased by 3.28% to $59.0 million in 2023, then changed by 0.0% to $59.0 million in 2024, then decreased by 28.81% to $42.0 million in 2025, then fell by 7.14% to $39.0 million in 2026.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $39.0 million, $42.0 million, and $61.0 million for Q1 2026, Q4 2025, and Q2 2025 respectively.